Department of Dermatology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
J Invest Dermatol. 2010 Jan;130(1):12-4. doi: 10.1038/jid.2009.332.
In this issue, Hacker and colleagues provide further evidence that molecular subtypes of malignant melanoma may develop along divergent pathways. The authors did not find an association between somatic BRAF-mutant melanoma and germline melanocortin-1 receptor (MC1R) gene status. We discuss this seeming paradox in light of previous studies demonstrating strong associations.
在本期中,Hacker 及其同事提供了进一步的证据,表明恶性黑色素瘤的分子亚型可能沿着不同的途径发展。作者没有发现体细胞 BRAF 突变型黑色素瘤与种系黑素皮质素 1 受体 (MC1R) 基因状态之间存在关联。我们根据先前的研究结果,对这一看似矛盾的现象进行了讨论,这些研究结果表明存在强烈的相关性。